Skip to main content
UKPMC Funders Author Manuscripts logoLink to UKPMC Funders Author Manuscripts
. Author manuscript; available in PMC: 2017 Feb 1.
Published in final edited form as: Nat Immunol. 2016 Aug 1;17(9):1093–1101. doi: 10.1038/ni.3522

Affinity for self antigen selects regulatory T cells with distinct functional properties

Lena Wyss 1, Brian D Stadinski 2, Carolyn G King 3, Sonja Schallenberg 4, Nicholas I McCarthy 5, Jun Young Lee 6, Karsten Kretschmer 4,7, Luigi M Terracciano 8, Graham Anderson 5, Charles D Surh 6,9, Eric S Huseby 2, Ed Palmer 1
PMCID: PMC4994872  EMSID: EMS69040  PMID: 27478940

Abstract

How regulatory T cells (Treg cell) control lymphocyte homeostasis is not fully understood. Here we identify two Treg cell populations with differing degrees of self-reactivity and distinct regulatory functions. Triplehi (GITRhiPD-1hiCD25hi) Treg cell are highly self-reactive and control lympho-proliferation in peripheral lymph nodes. Triplelo (GITRloPD-1loCD25lo) Treg cells are less self-reactive and limit development of colitis by promoting conversion of CD4+ Tconv cells into induced Treg cells (iTreg cells). Although Foxp3-deficient (scurfy) mice lack Treg cells, they contain Triplehi-like and Triplelo-like CD4+ T cells with distinct pathological properties. Scurfy TriplehiCD4+T cells infiltrate the skin whereas scurfy TripleloCD4+T cells induce colitis and wasting disease. These findings indicate that T cell receptor affinity for self-antigens drives the differentiation of Tregs into distinct subsets with non-overlapping regulatory activities.


The importance of CD4+ regulatory T cells (Treg cell) in maintaining lymphocyte homeostasis is best appreciated in mice and humans lacking these cells. Foxp3-deficient (scurfy) mice1,2,3 and patients with immunodysregulation polyendocrinopathy enteropathy X-linked (IPEX) syndrome4 suffer from excessive lymphocyte activation, lymphocytic infiltration into peripheral organs and colitis, leading to death at an early age. In healthy individuals, Treg cells control homeostatic proliferation of conventional T and B cells and prevent colitis5,6,7.

Treg cells are comprised of thymic Tregs (tTreg cell) and peripherally-induced Treg cells (pTreg cells or iTreg cells), which originate from different precursor cells and develop in different locations. tTreg cells develop in the thymus and their development requires TCR stimulation with agonist peptide- major histocompatibility complex (MHC)II antigens.8,9,10 In contrast, iTreg cells are generated in the periphery from naive, mature CD4+ conventional T cells (Tconv cells) during T cell activation in the presence of the cytokine TGF-β.11 Both populations are suppressive and their functional properties have been examined. Several studies suggest that tTreg cells are required to control immune homeostasis and autoimmunity.5,12,13 On the other hand, iTreg cells have specialized functions depending on the type of inflammation, and have a primary role in controlling mucosal immunity and fetal tolerance.5,12,13,14 However tTreg cells by themselves are not sufficient to suppress chronic inflammation and autoimmunity in the absence of iTreg cells.15

Treg cells have also been characterized for their expression of surface markers and localization in different tissues.16,17,18 Based on their expression of CD44 and the lymph node homing receptor, CD62L, Treg cells can be broadly divided into CD44loCD62L+ central Treg (cTreg) and CD44hiCD62Llo/– effector Treg (eTreg) cells.16 cTreg cells are quiescent, primarily reside in secondary lymphoid tissues, express high levels of CD25 and are interleukin-2 (IL-2)- dependent. In contrast, eTreg cells, the dominant Treg population in non-lymphoid tissues, are CD25lo, highly proliferative, but prone to apoptosis. It’s been suggested that eTreg cell maintenance is driven by TCR and co-stimulatory signals, but not IL-2.16

Several studies demonstrated the importance of TCR stimulation to activate cTreg cells in order to generate suppressive eTreg cells.8,9 Furthermore, studies have provided direct evidence that TCR expression is indispensable for Treg cell survival and suppressive function.19,20 The Treg cell repertoire contains self-reactive8,21,22 as well as foreign antigen reactive23 TCRs. The TCR affinity of Treg cells for self antigen has not yet been fully characterized. Although it’s generally accepted that Treg cells and naive CD4+ Tconv cells have non-overlapping TCR repertoires, a small percentage of TCRs are found within both CD4+ T cell populations.24,25 Furthermore, the TCR repertories of tTreg cells and iTreg cells were shown to be distinct.26,27 While the tTreg cell TCR repertoire is biased toward self-recognition, TCRs expressed in iTreg cells can recognize foreign antigens with high affinity.24,26 In line with these findings, it’s been shown that activated CD4+ T cells from TCRβ transgenic (TCRβ-tg) scurfy mice preferentially used TCRs found in the Treg cell TCR repertoire of TCRβ-tg wild type mice.21 Despite these interesting findings, it’s still not clear how a Treg cell’s antigen specificity influences its’ regulatory properties.

Here report two functionally distinct subgroups of tTreg cells with distinct TCR repertoires and differing TCR affinities for self-antigens. Triplelo (GITRloPD-1loCD25lo) Treg cells express TCRs whose affinities for self-antigens are close to the negative selection threshold, whereas Triplehi (GITRhiPD-1hiCD25hi) Treg cells express TCRs with affinities well above this threshold. Functionally, Triplelo Treg cells control colitis by facilitating conversion of CD4+ Tconv cells into iTreg cells, whereas Triplehi Treg cells maintain lymphocyte homeostasis within peripheral lymph nodes (LNs). Finally, Foxp3-deficient (scurfy) mice contain Triplehi- like and Triplelo- like CD4+ T cells with distinct pathological properties. Our results provide evidence that the degree of thymocyte self-reactivity drives the generation of distinct Treg cells subtypes, which control different aspects of lymphocyte homeostasis.

Results

Distinct Treg cell subsets

Foxp3+ Treg cells express a continuum of GITR and PD-1 (Fig 1a). As GITRhiPD-1hi Treg cells express higher levels of CD25 compared to GITRloPD-1lo Treg cells (Fig. 1a), we refer to these populations as Triplehi (GITRhiPD-1hiCD25hi) and Triplelo (GITRloPD-1loCD25lo) Treg cells, respectively. To compare these Treg cell populations to previously described Treg cells subsets16,17,18, we examined their expression of various homing and chemokine receptors (Fig. 1b) as well as transcription factor Helios and semaphoring receptor Nrp-1(Fig. 1c). Based on their expression of these proteins, Triplehi and TripleloTreg cells are distinct from each other and distinct from centralTreg and effectorTreg cells (Table 1;16,17,18). This analysis also shows that centralTreg and effectorTreg cells are contained within the Triple intermediate (Tripleint) gate (Supplementary Fig.1).

Figure 1.

Figure 1

Characterisation of Triplehi and Triplelo Treg cells. (a) Flow cytometry analyzing the expression of Foxp3, GITR and PD-1 and CD25 by CD4+ LN cells from 6-12 week old B6 mice. Numbers adjacent to outlined areas indicate percent of Foxp3+CD4+ cells (left; green) and frequencies of TriplehiTreg cells (GITRhiPD-1hiCD25hi, middle, red) and TripleloTreg cells (GITRloPD-1loCD25lo, middle, brown) among Foxp3+CD4+ cells (n= 6 mice). Middle left panel shows quantification of those results. Histogram (right) shows CD25 expression on Triplehi (red line) or Triplelo(brown, line) Treg cells (n=4 mice) and quantification of median fluorescence intensity (MFI) of those results. (b,c) Flow cytometry analyzing the expression of (b) CD44, CD62L, CD103, CCR7, ICOS and (c) Helios and Nrp-1 by Foxp3+CD4+ Triplehi (red lines and bars) and Triplelo (brown lines and bars) Treg cells from LNs of 6-12 week old B6 mice (n= 4 mice) and quantification of those results. Each symbol represents an individual mouse; bars graphs indicate the mean (± s.e.m.) NS = not significant (P> 0.05), *P≤ 0.01, **P≤ 0.001, ***P≤0.0001 (unpaired, two-tailed t-test). Data are from three (a) or two (b,c) independent experiments.

Table 1.

Comparing surface and intracellular marker expression of Triplehi, Triplelo, effector and central Treg cells.

CD44 CD62L CD25 ICOS CCR7 CD103 Helios Nrp-1
eTreg cells high low low high low high high (similar to cTreg cells) high (similar to cTreg cells)
TriplehiTreg cells high low high high int (similar to Triplelo Treg cells ) ~70% neg high high
cTreg cells low high high low high low high (similar to eTreg cells) high (similar to eTreg cells)
Triplelo Treg cells low high low low int (similar to Triplehi Treg cells ) ~90% neg low low

Origin of Triplehi and Triplelo Tregs

Triplehi and TripleloTreg cells present in the thymus (Fig. 2a) could represent Treg cells recirculating from the periphery as opposed to de novo generated tTreg cells.28,29 To resolve this, we examined thymic Treg cells in mice expressing Foxp3-RFP and Rag-GFP reporters (Fig. 2b). RFP+GFP+ CD4 single positive (SP) thymocytes are de novo generated thymic Treg cells since they are still Rag-GFP+, while RFP+GFP CD4SP cells in the thymus are recirculating Treg cells from the periphery.29 The frequency of de novo generated (RFP+GFP+) Triplehi and TripleloTreg cells in the thymus is similar to that observed among LN Treg cells. The fact that both Triplehi and TripleloTreg cells develop in the thymus argues against the idea that either population are iTreg cells. To address the possibility that Triplehi and TripleloTreg cells might be induced by foreign antigens or inflammation, we examined Treg cells in germ-free (GF) and antigen-free (AF) mice. AF mice are offspring of GF mice that were weaned onto and raised on the elemental diet of glucose and amino acids.30 As these animals lack a microbiome and are not exposed to dietary antigens, they contain exclusively self-antigens. GF and AF mice contain similar frequencies of LN Treg cells compared to standard SPF animals (Fig. 2c, top). Importantly, SPF, GF and AF mice contain similar frequencies of Triplehi and TripleloTreg cells (Fig. 2c, bottom), which also express similar levels of Nrp-1 and Helios protein (Supplementary Fig. 2). These data rule out the idea that the Triplehi and Triplelo phenotypes are a response to inflammation. Furthermore, these results strongly suggest that Triplehi and TripleloTreg cells are exclusively generated through recognition of self-antigens.

Figure 2.

Figure 2

Analysis of Triplehi and Triplelo Treg cell origin (a) Flow cytometry analyzing the expression of GITR and PD-1 on Foxp3+CD4 single positive (SP) thymocytes of 6-12 week old B6 mice. Numbers adjacent to outlined areas (left) indicate frequencies of Triplehi (red) and Triplelo (brown) Treg cells among Foxp3+CD4SP thymocytes. Bar graph (right) shows quantification of those results. (n=10 mice) (b) Flow cytometry analyzing expression of Rag-GFP reporter, GITR and PD-1 in Foxp3+CD4SP thymocytes from Foxp3-RFP Rag2-GFP dual-reporter mice. Numbers near bracketed lines indicate percent Rag-GFP (left) and Rag-GPF+ (right) among Foxp3+CD4SP thymocytes. Numbers adjacent to outlined areas indicate frequencies of Triplehi (red) and Triplelo (brown) Treg cells among recirculating (Rag-GPF, middle) and de novo generated thymic (Rag-GPF+, right) Treg cells. Bar graphs (middle right and far right) show quantification of those results. (n= 3 mice, data taken from 1 experiment) (c) Flow cytometry analyzing Foxp3, CD4, GITR and PD-1 expression in LN cells from specific pathogen free (SPF), germ free (GF) and antigen free (AF) B6 mice. Numbers adjacent to outlined areas indicates frequencies of Foxp3+CD4+ T cells (top row, gray) and Triplehi (red) and Triplelo (brown) Treg cells in these mice (bottom row). Bar graphs (right) show quantification of those results. (n=2 mice per group) Each symbol represents an individual mouse; bar graphs indicate the mean (± s.e.m.) NS = P> 0.05 (Kruskal-Wallis Test). Data are from five independent (a) or one (b,c) experiments.

Distinct Triplehi and Triplelo Treg cell TCR repertoires

To directly compare the TCR repertoires of Triplelo and TriplehiTreg cells to CD4+Tconvs cells, all three populations expressing the Vα2 family (Fig. 3a), were sorted from a Rag+, single TCRβ chain strain (Yae62, Vβ8.2, TCRα+/KO, Foxp3GFP–KI– Supplementary Fig. 3) and subjected to deep sequencing. The 500 most frequent clonotypes in each group were analyzed for their similarity (Fig. 3 b-d) and diversity (Fig. 3e,f). Morisita-Horn analysis, which measures sequence similarity shows that the CD4+Tconv sequences from three independent groups of mice (see Methods) are similar to each other but significantly different from Triplelo and Triplehi TCR sequences obtained from the same mice (Fig. 3b). Triplelo sequences isolated from different groups of mice are similar to each other as well, but different from CD4+Tconv and Triplehi TCRs (Fig. 3c). Triplehi TCR sequences are not only different from CD4+Tconv and Triplelo sequences, but they vary between different groups of mice (Fig. 3d). Despite their significant sequence differences, the TCR repertoires of CD4+Tconv cells and TripleloTreg cells are similarly diverse (Fig. 3e, f), while the TriplehiTreg cell TCR repertoire may be less diverse, at least according to Shannon Entropy analysis, which is used to measure sequence diversity. Taken together, deep sequencing showed that TriplehiTreg cells, TripleloTreg cell and CD4+Tconv cells have clearly distinct TCR repertoires, implying that TCR specificity is important in selecting these Treg cell subtypes.

Figure 3.

Figure 3

Sequence similarity analysis between Triplehi Treg, Triplelo Treg and CD4+Tconv TCRs. Vα2+ TCRα sequences generated from Triplehi Treg, Triplelo Treg and CD4+Tconv LN cells from Yae62 Vβ8.2 (single TCRβ chain), TCRα+/KO Foxp3-GFPKI mice. Sequences from each subset within each group of mice were individually compared to all subsets from all groups of mice. (a) Frequency of Vα2 expressing cells among CD4+ Tconv cells (blue), TriplehiTreg cells (red) and TripleloTreg cells (brown). Evaluation of TCR sequence similarity based on the Morisita-Horn similarity index (MHI) (b,c,d) MHI comparison of Vα2+ TCR sequences (b) CD4+ Tconv clonotypes (blue) were compared to each other and to Triplelo (brown) Treg and Triplehi (red) Treg clonotypes (c) TripleloTreg clonotypes (brown) were compared to each other and to CD4+Tconv (blue) and TriplehiTreg (red) clonotypes and (d) Triplehi Treg clonotypes (red) were compared to each other and to CD4 Tconv (blue) and Triplelo Treg (brown) clonotypes (see Methods for full description). Evaluation of TCR sequences diversity based on Shannon Entropy (e) and Simpson Diversity (f) scores (see Methods for full description). Each symbol represents the value from a group of mice (a) or sequences (e,f); in (b,c,d) each symbol represents a MHI comparison between clonotypes from two individual groups; small horizontal lines indicate the mean (± s.e.m.) NS = not significant (P> 0.058), *P=0.058, *P≤ 0.01, ***P≤0.001 (Mann-Whittney U test, b-d and unpaired, two-tailed t-test, e,f). Data are from one experiment with three independent groups of TCRβ chain mice (2 mice per group).

Self-reactivity of Triplehi and Triplelo Treg cells

To directly test whether Triplehi and Triplelo Treg cell differ in their degree of self-reactivity, we examined CD5 and Nur77 protein expression in each subset (Fig. 4a). The expression of these markers reflects T cell activation and correlates with TCR affinity for its peptide-MHC (pMHC) ligand.31,32 The higher expression of Nur77 and CD5 by Triplehi Treg cells, compared to Triplelo Treg cells (Fig. 4a) argued that Triplehi Treg cells are more self-reactive than their Triplelo Treg cell counterparts. To test this idea, we used in vivo BrdU labeling and observed that TriplehiTreg cells proliferate more frequently in vivo compared to TripleloTreg cell and CD4+Tconv cells (Fig. 4b). Furthermore, culturing unsorted CD4+T cells on syngeneic bone marrow dendritic cells (BMDCs), TriplehiTreg cells proliferate more extensively than TripleloTreg cells and CD4+Tconv cells (Fig. 4c); this proliferation requires expression of MHCII self-antigens on antigen presenting cells (APCs).

Figure 4.

Figure 4

Self-reactivity of Triplehi and Triplelo Treg cells. (a) Flow cytometry analyzing Triplehi (red) and Triplelo (brown) LN Treg cells from 6-10 week old B6 mice for CD5 (n=4 mice) and Nur77-GFP (n=2 mice) expression and quantification of MFI of those results. (b) Proliferation of LN-derived Triplehi Treg (red), Triplelo Treg (brown) and Tconv (blue) cells in vivo after intraperitoneal injection of BrdU into B6 mice (n=4 mice). Frequencies of BrdU incorporating (BrdU+) cells are shown. (c) Flow cytometry analyzing in vitro proliferation (CFSE dilution) of LN-derived Triplehi Treg (red) Triplelo Treg (brown) and CD4+Tconv (blue) cells from purified CFSE labeled CD4+LN-derived T cells cultured on B6 or B6.MHCII KO BMDCs. Representative histogram (left) and quantification of those results (numbers of proliferated cells, right) are shown (n= 5 biological replicates). (d) Flow cytometry analyzing GITR, PD-1, Foxp3 and CD4 expression by 3BK508TCR-tg CD4SP (top and middle row) or GITR and PD-1 expression by 3BK508TCR-tg Foxp3+CD4SP thymocytes (bottom row) after 48h of culture in the presence of P-1A, P2A, 3K or no peptide, mature B6 BMDCs as APCs, IL-2 and TGF-β (e) Flow cytometry analyzing expression of Foxp3, CD4 on OTII CD4SP thymocytes (left) and GITR and PD-1 on Foxp3+OTII CD4SP thymocytes obtained from chimeras generated by reconstitution of RIP-OVA (top) or B6 (bottom) hosts with a mixture of bone marrow cells from OTII Rag2–/– and B6 mice (n=4 mice each group). Numbers in quadrants indicate percent cells; numbers adjacent to outlined areas indicate (d, middle) percent Foxp3+ among 3BK508TCR-tg CD4SP and (e, left) percent of Foxp3+ among OTII CD4SP. Each symbol represents an individual chimera (a,b). Bar graphs indicate the mean (± s.e.m.). NS = not significant (P>0.054), *P≤ 0.054, **P≤ 0.01, ***P≤0.0001 (unpaired, two-tailed t-test). Data are from one (a, Nur77), two (a, CD5; b,c) independent experiments or from one representative experiment from at total of three (d) or two (e) independent experiments with similar results.

To examine the influence of antigen affinity on the generation of CD4SP thymocytes with a Triplehi or Triplelo phenotype (Fig. 4d), B3K508TCR-tg Rag2–/– thymocytes, expressing the B3K508 TCR and recognizing the 3K, P2A and P-1A peptides presented by I-Ab were cultured on syngeneic BMDCs in the presence of TGF-β and IL-2. Addition of P-1A peptide (high affinity threshold negative selector) induced development of Triplelo CD4SP thymocytes, while the P2A peptide (intermediate affinity negative selector) induced intermediate (Tripleint) CD4SP thymocytes; finally, 3K-peptide (high affinity negative selector) induced only Triplehi CD4SP thymocytes (Fig. 4d, top). Foxp3+Treg cells were also generated in these cultures, but only in the presence of negative selecting peptides (Fig. 4d, middle, Supplementary Fig. 4a). Culturing B3K508TCR-tg Rag2–/– thymocytes with the negative selecting ligands, P-1A, P2A and 3K generated Foxp3+Treg cells expressing increasing amounts of PD-1 (Fig 4d), CD25 and Helios protein (Supplementary Fig. 4b). Taken together, the data indicate that threshold-, intermediate- and high- affinity negative selecting antigens induce Triplelo, Tripleint and Triplehi Treg cells, respectively (Fig 4d, bottom; Supplementary Fig. 4b). That the threshold negative selector induces weaker TCR signals is supported by its decreased ability to induce pCD3ζ, pJun and pErk (Supplementary Fig. 4c,d). These in vitro results were confirmed using bone marrow chimeras, where OT-II thymocytes developed in a RIP-OVA host expressing the cognate antigen, ovalbumin in the thymus and the pancreas under the control of the rat insulin promoter (Fig. 4e). These chimeric mice contain Triplehi (and Tripleint) but not Triplelo Treg cells in the thymus. Taken together, these data imply that Triplehi and Triplelo Treg cells are likely generated by exposure to negatively selecting antigens; moreover, the resulting Treg cells phenotype is most likely determined by the affinity of its TCR for self-antigen.

Triplehi Treg cells suppress lymphoproliferation

To compare the regulatory properties of these two populations, Foxp3DTR mice received sorted Triplehi or Triplelo Treg cells from B6 mice (Supplementary Fig. 5a), which are unaffected by diphtheria toxin (DTx). Three days later, endogenous Treg cells from the Foxp3DTR host were depleted by injecting DTx every other day. LN lymphocytes then were examined by flow cytometry 11 days following the onset of Treg cells depletion (Supplementary Fig. 5b). Triplehi Treg cells control the extensive proliferation of T cells and B cells in peripheral LNs of mice depleted of their endogenous Treg cells (Fig. 5a), while Triplelo Treg cells function poorly in this respect. As expected, Triplehi Treg cells limit the activation of CD4+ Tconv cells (Fig. 5b,c). Taken together, these results show that Triplehi Treg cells regulate lymphocyte homeostasis in peripheral LNs.

Figure 5.

Figure 5

Triplehi but not Triplelo Treg cells suppress in vivo lymphoproliferation.

Analysis of in vivo suppressive function of sorted Ly5.2 Triplehi Treg, Ly5.2 Triplelo Treg cells or total Ly5.2 Treg cells transferred into 6-10 week old Ly5.1 Foxp3DTR mice treated every other day with diphtheria toxin (DTx). (a) Expansion of endogenous CD4+-(left), CD8+-(middle) or B- (right) cells of DTx-treated Ly5.1 Foxp3DTR mice, previously injected (intravenously) with Triplelo Treg (brown, n=4 mice), Triplehi Treg (red, n=6 mice) or total Treg (green, n=3 mice) cells was analyzed at d11-13 after cell transfer. DTx-treated Ly5.1 Foxp3DTR mice receiving no cells (black, n=10 mice) or DTx-treated B6 mice (gray, n=4 mice) were used as controls. (b) Representative flow cytometry analyzing CD44 and CD62L expression on endogenous CD4+ T cells, isolated from LNs of DTx treated Ly5.1 Foxp3DTR or B6 mice (described in a) (c) quantification of endogenous naive (CD44 CD62L+) CD4+ Tconv cells of the results in (b). Numbers in quadrants indicate percent cells in each throughout. Bar graphs indicate the mean (± s.e.m.). NS = not significant (P>0.05), *P≤ 0.05, **P≤ 0.001 (unpaired, two-tailed t-test). Data are from 2-4 independent experiments (a,b).

Triplelo Treg cells suppress induction of colitis

To examine whether any of these Treg cell subsets control colitis, CD3-deficient (Cd3e–/–) mice were injected with sorted naive CD4+ Tconv cells (Supplementary Fig. 6a), a treatment, which results in weight loss (Fig. 6a) and colitis (Fig. 6b, upper left panel) as previously described7. Co-transfer of Triplelo (Fig. 6a, solid brown line; Fig. 6b, upper middle panel) but not Triplehi (Fig. 6a, solid red line; Fig. 6b, upper right panel) Treg cells prevented weight loss and limited lymphocyte infiltration of the colonic mucosa. Analysis of LN cells from these mice indicated that co-transferred Triplelo Treg cells facilitated the conversion of some CD4+ Tconv cells into iTreg cells (Fig, 6c,d). Mice receiving TripleloTreg cells had the highest percentage of iTreg cells (Fig, 6c,d), very limited infiltration of the colonic mucosa (Fig. 6b, upper middle panel) and maintained their weight (Fig. 6a).

Figure 6.

Figure 6

Triplelo but not Triplehi Treg cells suppress colitis. Analysis of in vivo suppressive function of sorted Ly5.2 Triplehi Treg and Ly5.2 Triplelo Treg cells co-transferred with sorted, naive (CD4+CD25) CD4+ Tconv cells from B6 Ly5.1 (a,b,c,d CD4+ B6 Tconv cells) or Ly5.1 Foxp3DTR mice (b,c,d,e CD4+ Foxp3DTR Tconv cells) into 6-10 week old T cell-deficient CD3ε–/– mice. (a) Weight change in CD3ε–/– mice following intravenous adoptive transfer of CD4+ Tconv cells alone (blue, n=9 mice), CD4+ B6 Tconv + TripleloTreg cells (brown, n=9 mice) or CD4+ B6 Tconv + TriplehiTreg (red, n=6 mice) cells. CD3ε–/– mice injected with no cells (black, n=5) were used as controls. b) Hematoxylin-and-eosin staining of colon sections from CD3ε–/– mice adoptively transferred with cell populations indicated in a and e. Scale bar, 100μm. c) Flow cytometry analyzing of Foxp3 and CD4 expression by CD4+ B6 Tconv cells or CD4+ Foxp3DTR Tconv cells isolated from LNs and mesenteric LNs (mLN) from mice described in a and e six weeks after transfer. Numbers adjacent to outlined areas indicate frequencies of Foxp3+CD4+ (iTreg cells) among those cells and d) quantification of those results. e) Weight change in CD3ε–/– mice following intravenous adoptive transfer of CD4+ FoxP3DTR Tconv cells alone (dashed blue, n=3 mice) or CD4+ FoxP3DTR Tconv + TripleloTreg cells (dashed brown, n=3 mice). CD3ε–/– mice not receiving cells (black, n=5) were used as controls. All mice were treated with DTx. NS = not significant (P>0.068), *P=0.068, **P≤ 0.05, ***P≤ 0.01, ****P≤ 0.001(unpaired, two-tailed t-test). Data are from 2-4 independent experiments. Each symbol represents an individual mouse (d); mean ± s.e.m in (a,d,e).

To test whether iTreg cells were required to control colitis15, CD4+ Tconv cells isolated from Foxp3DTR mice were transferred into Cd3e–/–) mice (Supplementary Fig. 6a). These animals were additionally treated with DTx every third day to deplete any iTreg cells developing from transferred Foxp3DTR CD4+Tconv cells. iTreg cells depletion accelerated weight loss and development of colitis (compare solid blue Fig. 6a and dashed blue lines in Fig. 6e). Co-transferred B6 Triplelo Treg cells (unaffected by DTx) were unable to control the development of colitis when iTreg cells were depleted (compare solid brown Fig. 6a and dashed brown lines in Fig. 6e; compare upper middle and lower middle panels in Fig. 6b). The data support the idea that TripleloTreg cells facilitate conversion of some CD4+Tconv cells into Foxp3+ iTreg cells (Fig. 6d), which in aggregate limit development of colitis.

Taken together, the data (Fig. 5 and 6) argue for two populations of Treg cells: Triplehi Treg cells, which control lymphoproliferation in peripheral LNs and Triplelo Treg cells, which limit the development of colitis (at least in a lymphopenic setting). It should be noted that the phenotypes of Triplehi Treg cells are stable over the 11d time course of the experiment (Fig. 5) while Triplelo Treg cells are stable over the 6 week time course of the experiment (Fig. 6, Supplementary Fig. 6b). As Triplelo Treg cells did not suppress lympho-proliferation and Triplehi Treg cells did not suppress colitis, there was no evidence for a significant degree of trans-differentiation between the two subsets during the time frame of these experiments.

Triplehi and Triplelo CD4+ T cells in scurfy mice

Although Foxp3-deficient (scurfy) mice cannot develop Treg cells due to the lack of functional Foxp3, they do carry out negative selection.21 For this reason, we wondered whether scurfy mice contain Triplehi- like and Triplelo- like CD4+ T cells despite their lack of a functional Foxp3 molecule. Flow cytometry analysis shows that these mice contain GITRhiPD-1hiCD25hi (Scurfy Triplehi) and GITRloPD-1loCD25lo (Scurfy Triplelo) CD4+ T cells. Scurfy Triplehi CD4+ T cells resembled B6 Triplehi Treg cells in terms of PD-1, GITR, CD25, Helios, CD5 and CD62L protein expression (Fig. 7a). Given their lack of Foxp3 expression and suppressive capacity, Scurfy TriplehiCD4+ T cells may be similar to previously reported Treg ‘wannabes’.21,33,34 Scurfy Triplelo CD4+ T cells, on the other hand resembled CD4+ Tconv cells with respect to their expression of these markers (Fig. 7a).

Figure 7.

Figure 7

Foxp3-deficient (scurfy) mice contain B6 Treg cell-like cells with distinct pathogenicities. a) Flow cytometry analyzing the expression of GITR and CD25 on LN CD4+ T cells from Foxp3-deficient (scurfy) mice (top) and PD-1, GITR, CD25 (middle), Helios, CD5 and CD62L (bottom) expression by Scurfy Triplehi (PD-1hiGITRhiCD25hi; orange solid line) CD4+T cells, Scurfy Triplelo (PD-1negGITRnegCD25neg; purple solid line) CD4+ T cells, B6 CD4+ Triplehi Treg cells (dotted red line) and B6 CD4+ Tconv cells (dotted blue line) from 2-3 week old mice (n=4 mice each group). (b-d) Analysis of in vivo pathogenicity induced by sorted Scurfy Triplehi and Scurfy Triplelo CD4+ T cells isolated from sick, 2-3 week old FoxP3-deficient mice and adoptively transferred into 6-10 week old CD3ε–/– mice. (b) Weight change over time following intravenous adoptive transfer of Scurfy Triplehi (orange) or Scurfy Triplelo (purple) CD4+T cells into 6-10 week old CD3ε–/– mice (n= 14 mice each group). CD3ε–/– mice receiving no cells (black, n=7 mice) were used as controls. (c) Representative hematoxylin-and-eosin staining of colon and tail skin sections from CD3ε–/– mice adoptively transferred with cell populations indicated in (b) and B6 control mice. Scale bar, 100μm. (d) Numbers of Scurfy Triplehi (orange) and Scurfy Triplelo (purple) CD4+ T cells recovered from peripheral LNs and mLNs six weeks after cell transfer (n=10 mice each group). NS = not significant (P>0.05), *P≤ 0.05, **P≤ 0.001 (unpaired, two-tailed t-test). Data are from seven (b) or five (d) independent experiments or one experiment representative of two (a) or five (c) independent experiments with similar results; mean ± s.e.m in (b).

To investigate their pathological activities, Scurfy Triplelo and Scurfy Triplehi CD4+ T cells were sorted (Supplementary Fig. 7a) and separately transferred into T cell deficient, Cd3e–/–) hosts (Supplementary Fig. 7b). Transferred Scurfy TripleloCD4+ T cells promoted weight loss (Fig. 7b) and colitis (Fig. 7c). Moreover, they accumulated in mesenteric LNs (Supplementary Fig. 7c) where ~35% of these cells express α4β7, an integrin that enables homing to the gut35 (Supplementary Fig. 7d). In contrast, transferred Scurfy TriplehiCD4+ T cells do not cause weight loss (Fig. 7b) and preferentially accumulate in peripheral but not mesenteric LNs (Fig. 7d, Supplementary Fig. 7c). Moreover, Scurfy TriplehiCD4+ T cells induce massive inflammation in the skin but only minimal inflammation in the colon (Fig. 7c, Supplementary Fig. 7e). Taken together, these results indicate that the absence of normal Treg cells is not the sole cause of scurfy disease; the activity of dysregulated (Treg cell-like) Scurfy Triplehi CD4+ T cells accounts for some of the pathology observed in these mice.

Discussion

We examined the functionality of Treg cell subsets with distinct TCR repertoires and differing affinities for self-antigens. Our data suggest that Triplehi and Triplelo Treg cells are generated as an offshoot of negative selection. The high affinity self-reactive TCRs expressed by Triplehi Treg cells likely drive their selection in the thymus and their suppressive activity in peripheral LNs.36 On the other hand, thymic precursors expressing lower affinity self-reactive TCRs plausibly differentiate into Triplelo Treg cells. Triplehi and Triplelo Treg cells are distinct from central and effector Treg cell subsets based on their expression of CD25, CCR7, CD103, Helios and Nrp-1 proteins.16 Foxp3-RFP Rag-GFP dual reporter mice, clearly show that Triplehi and Triplelo Treg cell are present among de novo generated, Rag-GFP+, thymic Treg cells. Antigen free mice contain virtually no foreign antigens (they lack a microbiome and are fed an elemental diet), but express normal frequencies of Triplehi and Triplelo Treg cells; this demonstrates that their differentiation is driven exclusively by self-antigens. Taken together, these data demonstrate that Triplehi and Triplelo Treg cells are generated in a programmed fashion, based on their affinity for self-antigens.

Treg cells and CD4+ Tconvs cells are differently selected and have dissimilar TCR repertoires.24,25 A comparison of the TCR repertoires expressed in thymic and peripheral (induced) Treg cells is difficult due to the absence of specific markers for cell sorting.8,9,14,37,38 However, analysis of peripheral (assumed to be thymus-derived) and colonic (assumed to be peripherally induced) Treg cells revealed different TCR repertories expressed in these two populations.26 Deep sequencing shows that the TCR repertoires of Triplehi, Triplelo Treg and CD4+ Tconv cells indicates are distinct; this is expected if TCR specificity is linked to Treg cell differentiation. The decreased TCR diversity among Triplehi Treg cells may be due oligoclonal expansion; this is consistent with their increased proliferation in vivo.

Based on CD5 and Nur77-GFP reporter expression,31,32 the affinity hierarchy for self-reactivity is likely Triplehi Treg cells > Triplelo Treg cells > CD4+ Tconv cells. Exposing MHCII restricted TCR-tg thymocytes to threshold- (weak deleting), intermediate- (moderate deleting) or high- affinity (strong deleting) antigens generates Triplelo, Tripleint or Triplehi Treg cells, respectively. The principle that thymocyte affinity for self-antigen determines cell fate also applies to Treg cell development.

Whether different Treg cell populations suppress different aspects of autoimmunity is not fully known.15 Acute Treg cell ablation in Foxp3DTR mice leads to the activation of T cells specific for “available-antigens” including genome encoded self, environmental and food antigens.39 We show that the massive expansion of Tconv and B cells in Treg cell ablated mice is controlled by transferring Triplehi, but not Triplelo Treg cells. TriplehiTreg cells may suppress lymphoproliferation in peripheral LNs by either modifying DCs towards a tolerogenic phenotype41 or by directly interacting with Tconv cells.39, 40, 42

A number of reports show that co-transfer of Treg cells, in particular microbiota-specific Treg cells prevents the onset or even cures mice from colitis.7, 43, 44 iTreg cells are essential for maintaining immune homeostasis, especially at mucosal interfaces; additionally iTreg cells contribute to fetal tolerance.5,12,13 In the gut, naive CD4+T cells are converted into iTreg cell following TCR stimulation in the presence of TGF-β and IL-2; other compounds such as retinoic acid (RA) or short-chain-fatty-acids from microbiota mediate conversion as well.7 IL-10 is also a key player in maintaining lymphocyte homeostasis in the gut as IL-10 deficient mice suffer from spontaneous colitis.7 Our results clearly show that Triplelo Treg cells suppress colitis induction. Triplelo Treg cells by themselves do not control colitis induction, but function by promoting the generation of iTreg cells from CD4+ Tconv cells. To our knowledge, there is no study, showing that a particular Treg cell population can induce the conversion of CD4+ Tconv cells in iTreg cell in vivo. M2a macrophages were shown to promote a supportive environment for iTreg cells and directly contribute to immunological homeostasis in the gut.45 Nevertheless, how Triplelo Treg cells facilitate the generation of iTreg cells is still an open question.

Treg cell-like ‘wannabe’ CD4+ T cells accumulate in scurfy mice.33,34 These Treg cell-like Scurfy CD4+T cells are phenotypically similar to bona fide Treg cells and even express similar TCRs.21 Transfer of Tconv-like CD4+ T cells from scurfy mice resulted in colitis, but not the other features of scurfy disease.33 Here, we show that Scurfy Triplehi CD4+T cells are similar to bona fide Triplehi Treg cells with respect to PD-1, GITR, CD25 and Helios expression. Transferred Scurfy Triplehi CD4+T cells proliferate extensively in peripheral LNs, infiltrate the skin and cause cutaneous lesions similar to those seen in scurfy mice. Interestingly, IL-2 deficient scurfy mice do not develop skin lesions, while IL-4-, IL-6-, IL-10-, Stat6- or CD103- deficient scurfy mice do46 suggesting that IL-2 acts as an important mediator of skin inflammation in scurfy mice. Scurfy Triplehi CD4+T cells likely require but do not produce their own IL-2, since they express Helios, a repressor of IL-2 transcription.34 This might explain the accumulation of scurfy Triplehi CD4+T cells around IL-2 secreting, skin resident DCs in the dermis.47 In contrast, scurfy TripleloCD4+T cells induce severe colitis within four weeks when transferred to T cell deficient recipients. It’s unclear whether scurfy Triplelo CD4+T cells are the scurfy equivalent to B6 Triplelo Treg cells or to B6 CD4+ Tconv cells. A portion of Scurfy Triplelo CD4+T cells are likely to be microbiota specific, since germfree scurfy mice are less prone to develop colitis compared to scurfy mice housed under SPF conditions.26,36 Taken together, these results indicate that scurfy disease is pleiotropic. Although the absence of bona fide Treg cells is the major contributor to the scurfy phenotype, the presence of dysregulated Treg cells-like cells very likely initiates several pathological aspects of this disease.

In summary, our results show that the extent of self-reactivity underlies the development of two distinct populations of regulatory T cells. The highly self-reactive Triplehi Treg cells control the homeostatic proliferation of lymphocytes in peripheral LNs, whereas the less self-reactive Triplelo Treg cells facilitate the generation of iTreg cells in order to maintain lymphocyte homeostasis in the colon. Scurfy mice contain dysregulated Treg cells-like CD4+ T cells, which contribute to the pathology of scurfy disease.

Methods

Mice

CD45.1 congenic C57BL/6 (B6 Ly5.1, strain:002014), CD45.2 congenic C57BL/6J (B6, strain:000664), RIP-OVA mice expressing a membrane bound form of Ova under the control of the rat insulin promoter (RIP, strain: 005433)48,49 OTII TCR-tg mice recognizing IAb-OVA323-339 (strain: 004194)50, B6.Nur77-GFP(strain: 018974)31 and Foxp3-deficient (scurfy, strain: 019933) mice51 were all obtained from The Jackson Laboratory (Bar Harbor, ME). 3BK506 TCR-tg and 3BK508TCR-tg mice recognizing IAb-3K and mice deficient for MHC class II, invariant chain and Rag2 gene (referred here as MHCII KO mice) were provided by P. Marrack and J. Kappler (Denver, USA) and are described elsewhere52. Foxp3DTR mice39 were kindly provided by A. Rudensky (New York, USA). Foxp3eGFP and CD3e–/– mice were kindly provided by T. Rolink (Basel, Switzerland) and single TCR-β chain (OT-I Vβ5) transgenic mice kindly provided by D. Zehn (Lausanne, Switzerland) and are described elsewhere.53,54,55 Male Foxp3-deficient mice were used at 2-3 weeks of age, for all other strains, male and female mice at the age of 5-12 weeks were used for experiments. Mice were housed under specific pathogen-free conditions and bred in our colony (University Hospital Basel) in accordance with Cantonal and Federal laws of Switzerland. Animal protocols were approved by the Cantonal Veterinary Office of Baselstadt, Switzerland. Mice expressing the YAe62TCRβ-chain56,57 and all mouse sub-lines were maintained in a pathogen-free environment in accordance with institutional guidelines in the Animal Care Facility at the University of Massachusetts Medical School. Foxp3.RFP/GFP mice on the B6 background were bred and maintained at the animal facility of the CRTD (Dresden, Germany) under specific pathogen-free conditions; animal experiments were performed in accordance with the German law on care and use of laboratory animals and approved by the Regieriungspräsidium Dresden. Antigen free and germ free B6 mice30 were bred and maintained at the animal facility of the Pohang University of Science and Technology. This research was approved by the Institutional Animal Care and Use Committees (IACUC) of the Pohang University of Science and Technology (2013-01-0012). Mouse care and experimental procedures were performed in accordance with all institutional guidelines for the ethical use of non-human animals in research and protocols from IACUC of the Pohang University of Science and Technology. Foxp3-RFP Rag-GFP dual reporter mice29 on the B6 background were bred and maintained at the animal facility of the Biomedical Services Unit at the University of Birmingham and all experiments were performed in accordance with local and national Home Office regulations.

Flow Cytometry and cell sorting

Thymocytes and lymphocytes were stained with LIVE/DEAD Fixable near-IR stain Kit (Life Technologies, Invitrogen) and surface antibodies against CD3 (145-2C11), CD4 (RM4-5), CD5 (53-7.3), CD8 (53.58), CD19 (ID3), CD25 (PC61), CD44 (IM7), CD45.1 (A20), CD45.2 (104), CD45R (B220, RA3-6B2), CD62L (MEL-14), CD103 (2E7), CD197 (CCR7, 4B12), CD278 (ICOS, 7E.17G9), CD279 (PD-1, RMP 1-30), CD357 (GITR, DAT-1/ YGITR765), Nrp-1 (polyclonal), TCRβ (H57-597) and α β (DATK32). Intracellular staining for Foxp3 (FJK-16s/ 150D), Helios (22F6), pcJun (D47G9), pCD3ζ (K25-407.69) and pErk (197G2) was performed using the Foxp3 staining kit (eBioscience). All antibodies have been validated by their suppliers and references can be found on their website or on the online validation databases Antibodypedia and 1DegreeBio. Antibody dilutions were 1:100 for surface stainings and 1:50 for intracellular stainings. For BrdU experiments, mice were injected with 1mg/d BrdU (5-bromodeoxyuridine, BD Bioscience) for 3 days and cells were then stained for incorporated BrdU using a BrdU Flow Kit (BD Bioscience) followed by staining for intracellular markers. All antibodies were purchased from BD Bioscience, BioLegend, eBioscience or CellSignaling Technology. For flow cytometric analysis, a FACS CantoII (BD Bioscience) and FlowJo software (TreeStar) were used. For cell isolation, CD4+T cells were enriched using Dynabeads® Untouched™ Mouse CD4 Cells Kit (Life Technologies, Invitrogen) from cell suspensions from different sources (peripheral LN, mesenteric LN, spleen); subpopulations of enriched CD4 cells were further sorted on a FACSAriaIII or Influx cell sorter (BD Biosciences). Cell numbers were determined using AccuCheck Counting Beads (Life Technologies, Invitrogen) according to manufacturer’s instructions. All kits were used according to manufacturer’s instructions.

In vitro assays

Bone marrow derived DCs (BMDCs) were generated from bone marrow cells of 5-7 week old B6 or B6.MHCII KO mice. Bone marrow cells were cultured under maturation conditions for 10 days in full medium supplemented with GM-CSF (hybridoma supernatant, LUTZ-GMCSF, kindly provided by V.Horejsi). Autologous mixed lymphocyte reactions (auto-MLRs) were performed by co-culturing 1x105 syngeneic (B6 or MHCII KO) BMDCs with 3x105 CFSE labeled (Life Technologies, Invitrogen) magnetic bead enriched CD4 cells (Dynabeads, Invitrogen) in 96-well-U-shaped plates for 5 days. For in vitro, Treg cell development experiments, 1x105 thymocytes from 3BK508TCR-tg mice were co-cultured with 1x105 B6 BMDCs in the presence of IL-2 (25U/ml, hybridoma X63 supernatant) and recombinant mouse TGF-β1 (10ng/ml, R&D Systems) for 48h with or without 1μM 3K (FEAQKAKANKAV), P2A (FEAAKAKANKAVD) or P-1A (FAAQKAKANKAVD) peptides (all obtained from Eurogentec). Re-aggregated thymic organ cultures were performed as previously described.58 In brief, RTOC were established from B3K508TCR-tg, MHCII KO thymocytes and thymic epithelial cells from B6 mice and were cultured in presence of P-1A (20 μM), P2A (2 μM) or 3K (0.2 μM) peptides for 7 days before analysis. All in vitro assays were performed at 37°C in 5% CO2 using complete RPMI medium (GIBCO, Life Technologies).

Generation of bone marrow chimeric mice

For generating bone marrow chimeric mice, the protocol from Koehli et al.49 was adapted. Recipient mice (CD45.1 CD45.2) were lethally irradiated with 900 rad (GammaCell, Best Theratronics, CA). Bone marrow cells from 5-8 week old B6 mice (CD45.1) and OT-II Rag2–/– mice (CD45.2) were isolated and depleted of mature CD4+ and CD8+ T cells. A mixture of 9:1 of B6 and OT-II Rag2–/– bone marrow cells (4x106 total cells) were injected intravenously (i.v.) into irradiated recipient mice. Mice were analyzed 12-14 weeks after reconstitution and treated with antibiotics (Nopil, Mepha Pharma AG) in the drinking water until 2 weeks before analysis. The congenic markers CD45.1 and CD45.2 were used to identify T cells derived from different donor bone marrows as well as the host.

In vivo suppression assays

Foxp3DTR mice were injected intra-peritoneal (i.p.) with Diphtheria Toxin (DTx) (Calbiochem) every other day for 10-12 days (first and second injection 50μg/kg; subsequent injections 25μg/kg). In some groups, 2.5x105 sorted Treg cells from pooled LNs were injected i.v. 3 days prior to first DTx injection. Mice were analyzed one day after last their DTx injection. For colitis experiments, 6-10 week old T cell deficient CD3ε–/– mice received (i.v.) 3.2x105 sorted naive CD4+ T cells from pooled LNs of B6Ly5.1 or Foxp3DTR Ly5.1 mice. In some groups, 0.8 x105 sorted Treg cells from pooled LN were co-transferred. Recipients of naive Foxp3DTR CD4+ T cells (CD4+GFP) were injected every third day with DTx (10μg/kg), i.p. For adoptive transfer of Scurfy CD4+ T cells, 6-10 week old T cell deficient CD3ε–/– were reconstituted with 5x105 sorted CD4+ subpopulations from pooled LNs of 2-3 week old sick Foxp3-deficient (scurfy) male mice. Recipient mice were weighed weekly at the same time of day and sacrificed when initial body weight droped more than 20% or at the latest six weeks after T cell transfer. The congenic markers, Ly5.1 and Ly5.2 were used to identify T cells from the different donors as well the host. Tissue samples were fixed in 4% paraformaldehyde, embedded in parafin, sectioned and stained with hematoxylin and eosin.

Histology

Formalin-fixed tissues were processed, stained with hematoxylin and eosin and evaluated blindly.

Clonotype Analysis

Naive CD4+ (CD4+CD25Foxp3 ), TripleloTreg (CD4+CD25loFoxp3+GITRlo PD-1lo) or TriplehiTreg (CD4+CD25hiFoxp3+GITRhiPD-1hi) cell populations were sorted from 3 replicate groups (2 mice per group) of single TCRβ-tg (B6.YAe62β˜tg+TCRα+/–) mice were sorted to 98% purity (FACS Aria, BD Biosciences). RNA was isolated using Trizol and precipitated with RNase free glycogen (Invitrogen) following the manufactures protocol. cDNA was prepared using oligo-dT’s (Promega) and Omniscript RT kit (Qiagen). cDNA was amplified with 20 rounds PCR with generic Vα2 primer (5’-CCCTGGGGAAGGCCCTGCTCTCCTGATA-3’) and TCR Cα primer (5’-GGTACACAGCAGGTTCTGGGTTCTGGATG-3’). 1/10th volume of the first round PCR was amplified with an additional 20 rounds of PCR using barcoded primers, for post sequence identification of originating T cell population, containing Illunima PE read primer and P5/7 regions, respectively. The resulting 300bp fragment was gel purified (Gene Clean II, MP Biomedicals) and sequenced on a MiSeq using a single read 250bp run (Illumina). Sequence data sets were parsed by barcode using the program fastq-multx59 and clonotypes for each population were tabulated using TCRklass60.

Similarity and Diversity analysis of TCR clonotypes

The similarity of TCRs utilized within each population was quantified using the Morisita-Horn similarity index, 0 (minimal similarity) and 1 (maximal similarity). The Morisita-Horn (M-H) similarity indexes were calculated by tabulating the frequency in which the top 500 clonotypes of an individual population from one replicate sample was found in all other populations, using EstimateS Ver9.1.061 software. Statistical significance for M-H index values was assessed using a Mann-Whittney U test, GraphPad Prism version 6.04. The diversity of TCR repertoire for each population was measured using the top 500 most frequent clonotypes. The Shannon Entropy62 value for each sample was calculated as H = −Σpilog2 pi, where pi is the frequency of the clonotype within the top 500 clonotypes. Lower H values indicate lower diversity. Additionally, the Simpson's diversity index63 using the formula Ds = 1 − Σ[ni(ni − 1)]/[N(N − 1)], where ni is the TCR clone size of the ith clonotype and N is the total number of the top 500 clonotypes sampled. The index ranges from 0 to 1 with 1 indicating high diversity.

Statistical analysis

Statistical analyses were performed using Prism 6.0 (Graphpad software). If not other indicated, Students t test (unpaired, two-tailed) was used to assess statistical significance.

Supplementary Material

Supplementary Figures

Acknowledgements

We thank U. Schneider for animal husbandry. E. Traunecker and T. Krebs for cell sorting; and G. DeLibero, L. Jeker and O. Stepanek for reviewing the manuscript. This study was funded by grants 310030-149972/1 [SNF], Sybilla [EU FP7], and TerraIncognita [ERC] (E.P.); RO1-DK095077, U19 AI109858 and UMass DERC grant DK32520 (E.S.H.); T32 AI 007349 (B.D.S.); Federal Ministry of Education and Research grant (BMBF), German Center for Diabetes Research (grant DZD e.V., FKZ01GI0924) and Center for Regenerative Therapies Dresden, Cluster of Excellence grant FZT 111 (K.K), Programme Grant from MRC (G.A.); Project IBS-R005-D1 from the Inst. for Basic Science, Korean Ministry of Science (C.D.S.) and Oncosuisse KFS-3169 (L.M.T).

Footnotes

Accession codes

NCBI Sequence Read Archive: TCR sequence data, BioProject PRJNA325246

Author Contributions

L.W. and E.P. conceived and designed the experiments. L.W. performed all experiments except the following: thymic RTOCs carried out by C.G.K; analysis of Tregs in Foxp3.RFP/GFP mice, carried out by S.S. and K.K.; deep sequencing and analysis of TCR clonotypes, carried by B.D.S. and E.S.H; analysis of thymic Tregs in Foxp3-RFP / Rag-GFP dual reporter mice, carried out by N.I.M. and G.A.; analysis of Tregs in GF, AF and SPF mice, carried out by J.Y.L. and C.D.S.; and evaluation of histological sections, carried out by L.M.T. The manuscript was written by L.W. and E.P. All co-authors have read the manuscript.

Competing Financial Interests.

The authors declare no competing financial interests.

References

  • 1.Fontenot JD, Gavin MA, Rudensky AY. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat Immunol. 2003;4:330–336. doi: 10.1038/ni904. [DOI] [PubMed] [Google Scholar]
  • 2.Khattri R, Cox T, Yasayko SA, Ramsdell F. An essential role for Scurfin in CD4+CD25+ T regulatory cells. Nat Immunol. 2003;4:337–342. doi: 10.1038/ni909. [DOI] [PubMed] [Google Scholar]
  • 3.Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science. 2003;299:1057–1061. [PubMed] [Google Scholar]
  • 4.Bennett CL, et al. The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat Genet. 2001;27:20–21. doi: 10.1038/83713. [DOI] [PubMed] [Google Scholar]
  • 5.Josefowicz SZ, Lu LF, Rudensky AY. Regulatory T cells: mechanisms of differentiation and function. Annu Rev Immunol. 2012;30:531–564. doi: 10.1146/annurev.immunol.25.022106.141623. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Ohkura N, Kitagawa Y, Sakaguchi S. Development and maintenance of regulatory T cells. Immunity. 2013;38:414–423. doi: 10.1016/j.immuni.2013.03.002. [DOI] [PubMed] [Google Scholar]
  • 7.Harrison OJ, Powrie FM. Regulatory T cells and immune tolerance in the intestine. Cold Spring Harb Perspect Biol. 2013;5 doi: 10.1101/cshperspect.a018341. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Jordan MS, et al. Thymic selection of CD4+CD25+ regulatory T cells induced by an agonist self-peptide. Nat Immunol. 2001;2:301–306. doi: 10.1038/86302. [DOI] [PubMed] [Google Scholar]
  • 9.Apostolou I, Sarukhan A, Klein L, von Boehmer H. Origin of regulatory T cells with known specificity for antigen. Nat Immunol. 2002;3:756–763. doi: 10.1038/ni816. [DOI] [PubMed] [Google Scholar]
  • 10.Klein L, Jovanovic K. Regulatory T cell differentiation: turning harmful into useful. Immunity. 2012;37:441–443. doi: 10.1016/j.immuni.2012.09.002. [DOI] [PubMed] [Google Scholar]
  • 11.Chen W, et al. Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3. The Journal of experimental medicine. 2003;198:1875–1886. doi: 10.1084/jem.20030152. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Zheng Y, et al. Role of conserved non-coding DNA elements in the Foxp3 gene in regulatory T-cell fate. Nature. 2010;463:808–812. doi: 10.1038/nature08750. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Samstein RM, Josefowicz SZ, Arvey A, Treuting PM, Rudensky AY. Extrathymic generation of regulatory T cells in placental mammals mitigates maternal-fetal conflict. Cell. 2012;150:29–38. doi: 10.1016/j.cell.2012.05.031. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Yadav M, et al. Neuropilin-1 distinguishes natural and inducible regulatory T cells among regulatory T cell subsets in vivo. J Exp Med. 2012;209:1713–1722. S1711–1719. doi: 10.1084/jem.20120822. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Haribhai D, et al. A requisite role for induced regulatory T cells in tolerance based on expanding antigen receptor diversity. Immunity. 2011;35:109–122. doi: 10.1016/j.immuni.2011.03.029. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Smigiel KS, et al. CCR7 provides localized access to IL-2 and defines homeostatically distinct regulatory T cell subsets. J Exp Med. 2014;211:121–136. doi: 10.1084/jem.20131142. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Huehn J, et al. Developmental stage, phenotype, and migration distinguish naive- and effector/memory-like CD4+ regulatory T cells. J Exp Med. 2004;199:303–313. doi: 10.1084/jem.20031562. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Miyara M, et al. Functional Delineation and Differentiation Dynamics of Human CD4+ T Cells Expressing the Foxp3 Transcription Factor. Immunity. 2009;30:899–911. doi: 10.1016/j.immuni.2009.03.019. [DOI] [PubMed] [Google Scholar]
  • 19.Levine AG, Arvey A, Jin W, Rudensky AY. Continuous requirement for the TCR in regulatory T cell function. Nat Immunol. 2014;15:1070–1078. doi: 10.1038/ni.3004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Schmidt AM, et al. Regulatory T cells require TCR signaling for their suppressive function. J Immunol. 2015;194:4362–4370. doi: 10.4049/jimmunol.1402384. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Hsieh CS, Zheng Y, Liang Y, Fontenot JD, Rudensky AY. An intersection between the self-reactive regulatory and nonregulatory T cell receptor repertoires. Nat Immunol. 2006;7:401–410. doi: 10.1038/ni1318. [DOI] [PubMed] [Google Scholar]
  • 22.Lee H-M, Bautista JL, Scott-Browne J, Mohan JF, Hsieh C-S. A Broad Range of Self-Reactivity Drives Thymic Regulatory T Cell Selection to Limit Responses to Self. Immunity. 2012;37:475–486. doi: 10.1016/j.immuni.2012.07.009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Pacholczyk R, et al. Nonself-antigens are the cognate specificities of Foxp3+ regulatory T cells. Immunity. 2007;27:493–504. doi: 10.1016/j.immuni.2007.07.019. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Hsieh CS, et al. Recognition of the peripheral self by naturally arising CD25+ CD4+ T cell receptors. Immunity. 2004;21:267–277. doi: 10.1016/j.immuni.2004.07.009. [DOI] [PubMed] [Google Scholar]
  • 25.Pacholczyk R, Ignatowicz H, Kraj P, Ignatowicz L. Origin and T cell receptor diversity of Foxp3+CD4+CD25+ T cells. Immunity. 2006:249–259. doi: 10.1016/j.immuni.2006.05.016. [DOI] [PubMed] [Google Scholar]
  • 26.Lathrop SK, et al. Peripheral education of the immune system by colonic commensal microbiota. Nature. 2011;478:250–254. doi: 10.1038/nature10434. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Yadav M, Stephan S, Bluestone JA. Peripherally induced tregs - role in immune homeostasis and autoimmunity. Front Immunol. 2013;4:232. doi: 10.3389/fimmu.2013.00232. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Yang E, Zou T, Leichner TM, Zhang SL, Kambayashi T. Both retention and recirculation contribute to long-lived regulatory T-cell accumulation in the thymus. Eur J Immunol. 2014;44:2712–2720. doi: 10.1002/eji.201444529. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Cowan JE, McCarthy NI, Anderson G. CCR7 Controls Thymus Recirculation, but Not Production and Emigration, of Foxp3(+) T Cells. Cell Rep. 2016;14:1041–1048. doi: 10.1016/j.celrep.2016.01.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Kim KS, et al. Dietary antigens limit mucosal immunity by inducing regulatory T cells in the small intestine. Science. 2016;351:858–863. doi: 10.1126/science.aac5560. [DOI] [PubMed] [Google Scholar]
  • 31.Moran AE, et al. T cell receptor signal strength in Treg and iNKT cell development demonstrated by a novel fluorescent reporter mouse. J Exp Med. 2011;208:1279–1289. doi: 10.1084/jem.20110308. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Mandl JN, Monteiro JP, Vrisekoop N, Germain RN. T cell-positive selection uses self-ligand binding strength to optimize repertoire recognition of foreign antigens. Immunity. 2013;38:263–274. doi: 10.1016/j.immuni.2012.09.011. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Kuczma M, et al. Foxp3-deficient regulatory T cells do not revert into conventional effector CD4+ T cells but constitute a unique cell subset. The Journal of Immunology. 2009;183:3731–3741. doi: 10.4049/jimmunol.0800601. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Lin W, et al. Regulatory T cell development in the absence of functional Foxp3. Nat Immunol. 2007;8:359–368. doi: 10.1038/ni1445. [DOI] [PubMed] [Google Scholar]
  • 35.Wagner N, et al. Critical role for beta7 integrins in formation of the gut-associated lymphoid tissue. Nature. 1996;382:366–370. doi: 10.1038/382366a0. [DOI] [PubMed] [Google Scholar]
  • 36.Killebrew JR, et al. A self-reactive TCR drives the development of Foxp3+ regulatory T cells that prevent autoimmune disease. The Journal of Immunology. 2011;187:861–869. doi: 10.4049/jimmunol.1004009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Thornton AM, et al. Expression of Helios, an Ikaros Transcription Factor Family Member, Differentiates Thymic-Derived from Peripherally Induced Foxp3+ T Regulatory Cells. The Journal of Immunology. 2010;184:3433–3441. doi: 10.4049/jimmunol.0904028. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Weiss JM, et al. Neuropilin 1 is expressed on thymus-derived natural regulatory T cells, but not mucosa-generated induced Foxp3+ T reg cells. J Exp Med. 2012;209:1723–1742, S1721. doi: 10.1084/jem.20120914. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Kim JM, Rasmussen JP, Rudensky AY. Regulatory T cells prevent catastrophic autoimmunity throughout the lifespan of mice. Nat Immunol. 2007;8:191–197. doi: 10.1038/ni1428. [DOI] [PubMed] [Google Scholar]
  • 40.Liu K, et al. In vivo analysis of dendritic cell development and homeostasis. Science. 2009;324:392–397. doi: 10.1126/science.1170540. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Morelli AE, Thomson AW. Tolerogenic dendritic cells and the quest for transplant tolerance. Nat Rev Immunol. 2007;7:610–621. doi: 10.1038/nri2132. [DOI] [PubMed] [Google Scholar]
  • 42.Tadokoro CE, et al. Regulatory T cells inhibit stable contacts between CD4+ T cells and dendritic cells in vivo. J Exp Med. 2006;203:505–511. doi: 10.1084/jem.20050783. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Mottet C, Uhlig HH, Powrie F. Cutting edge: cure of colitis by CD4+CD25+ regulatory T cells. J Immunol. 2003;170:3939–3943. doi: 10.4049/jimmunol.170.8.3939. [DOI] [PubMed] [Google Scholar]
  • 44.Round JL, Mazmanian SK. Inducible Foxp3+ regulatory T-cell development by a commensal bacterium of the intestinal microbiota. Proc Natl Acad Sci U S A. 2010;107:12204–12209. doi: 10.1073/pnas.0909122107. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Haribhai D, et al. Alternatively Activated Macrophages Boost Induced Regulatory T and Th17 Cell Responses during Immunotherapy for Colitis. J Immunol. 2016 doi: 10.4049/jimmunol.1501956. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Sharma R, Sung SS, Gaskin F, Fu SM, Ju ST. A novel function of IL-2: chemokine/chemoattractant/retention receptor genes induction in Th subsets for skin and lung inflammation. J Autoimmun. 2012;38:322–331. doi: 10.1016/j.jaut.2012.02.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Zelante T, Fric J, Wong AY, Ricciardi-Castagnoli P. Interleukin-2 production by dendritic cells and its immuno-regulatory functions. Front Immunol. 2012;3:161. doi: 10.3389/fimmu.2012.00161. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Kurts C, et al. CD4+ T cell help impairs CD8+ T cell deletion induced by cross-presentation of self-antigens and favors autoimmunity. J Exp Med. 1997;186:2057–2062. doi: 10.1084/jem.186.12.2057. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Koehli S, Naeher D, Galati-Fournier V, Zehn D, Palmer E. Optimal T-cell receptor affinity for inducing autoimmunity. Proc Natl Acad Sci U S A. 2014;111:17248–17253. doi: 10.1073/pnas.1402724111. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Barnden MJ, Allison J, Heath WR, Carbone FR. Defective TCR expression in transgenic mice constructed using cDNA-based alpha- and beta-chain genes under the control of heterologous regulatory elements. Immunol Cell Biol. 1998;76:34–40. doi: 10.1046/j.1440-1711.1998.00709.x. [DOI] [PubMed] [Google Scholar]
  • 51.Lin W, et al. Allergic dysregulation and hyperimmunoglobulinemia E in Foxp3 mutant mice. J Allergy Clin Immunol. 2005;116:1106–1115. doi: 10.1016/j.jaci.2005.08.046. [DOI] [PubMed] [Google Scholar]
  • 52.Huseby ES, et al. How the T cell repertoire becomes peptide and MHC specific. Cell. 2005;122:247–260. doi: 10.1016/j.cell.2005.05.013. [DOI] [PubMed] [Google Scholar]
  • 53.Malissen M, et al. Altered T cell development in mice with a targeted mutation of the CD3-epsilon gene. EMBO J. 1995;14:4641–4653. doi: 10.1002/j.1460-2075.1995.tb00146.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54.Wang Y, et al. Th2 Lymphoproliferative Disorder of LatY136F Mutant Mice Unfolds Independently of TCR-MHC Engagement and Is Insensitive to the Action of Foxp3+ Regulatory T Cells. The Journal of Immunology. 2008;180:1565–1575. doi: 10.4049/jimmunol.180.3.1565. [DOI] [PubMed] [Google Scholar]
  • 55.Zehn D, Bevan MJ. T cells with low avidity for a tissue-restricted antigen routinely evade central and peripheral tolerance and cause autoimmunity. Immunity. 2006;25:261–270. doi: 10.1016/j.immuni.2006.06.009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56.Stadinski BD, et al. A role for differential variable gene pairing in creating T cell receptors specific for unique major histocompatibility ligands. Immunity. 2011;35:694–704. doi: 10.1016/j.immuni.2011.10.012. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57.Vanguri V, Govern CC, Smith R, Huseby ES. Viral antigen density and confinement time regulate the reactivity pattern of CD4 T-cell responses to vaccinia virus infection. Proc Natl Acad Sci U S A. 2013;110:288–293. doi: 10.1073/pnas.1208328110. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 58.White A, Jenkinson E, Anderson G. Reaggregate thymus cultures. J Vis Exp. 2008 doi: 10.3791/905. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 59.Aronesty E. ea-utils : “Command-line tools for processing biological sequencing data”. 2011 [cited]Available from: http://code.google.com/p/ea-utils.
  • 60.Yang X, et al. TCRklass: a new K-string-based algorithm for human and mouse TCR repertoire characterization. J Immunol. 2015;194:446–454. doi: 10.4049/jimmunol.1400711. [DOI] [PubMed] [Google Scholar]
  • 61.Colwell FS, et al. Estimates of biogenic methane production rates in deep marine sediments at Hydrate Ridge, Cascadia margin. Appl Environ Microbiol. 2008;74:3444–3452. doi: 10.1128/AEM.02114-07. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 62.Shannon CE. A Mathematical Theory of Communication. At&T Tech J. 1948;27:379–423. [Google Scholar]
  • 63.Simpson EH. Measurement of Diversity. Nature. 1949;163:688–688. [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supplementary Figures

RESOURCES